BRCA2 and breast carcinoma: Furthermore, BRCA2 mutation/deletion is far more common in prostate cancer than BRCA1 loss of function, whereas in breast cancer, the relative frequencies on BRCA1 versus BRCA2 mutation are nearly equal (1).